Related Experiment Videos
Endothelium-dependent responses and inhibition of angiotensin-converting enzyme
1Institut de Recherches Internationales Servier, Courbevoie, France.
Insights
Angiotensin-converting enzyme (ACE) inhibitors improve cardiovascular health by enhancing endothelial function. These drugs protect bradykinin, boosting the release of vital relaxing factors for better blood vessel function.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Endothelial Biology
Background:
- Cardiovascular diseases like hypertension and atherosclerosis are linked to endothelial dysfunction.
- Endothelial dysfunction involves impaired production of relaxing factors such as nitric oxide.
- Aging also contributes to reduced endothelial function.
Purpose of the Study:
- To investigate the role of ACE inhibitors in cardiovascular diseases.
- To explore the mechanisms behind the beneficial effects of ACE inhibitors on endothelial function.
- To understand how ACE inhibitors influence vasoactive endothelial factors.
Main Methods:
- Review of experimental and clinical studies on ACE inhibitors.
- Analysis of data on structural and functional cardiovascular improvements.
- Examination of the impact of ACE inhibitors on endothelial-derived relaxing factors.
Main Results:
- ACE inhibitors demonstrate efficacy in treating various cardiovascular conditions.
- Studies report both structural and functional improvements in patients treated with ACE inhibitors.
- ACE inhibitors may enhance endothelial function by protecting bradykinin.
Conclusions:
- ACE inhibitors offer significant benefits in managing cardiovascular diseases.
- Protection of bradykinin by ACE inhibitors contributes to augmented release of endothelial relaxing factors.
- These mechanisms underscore the therapeutic potential of ACE inhibitors in cardiovascular health.
Abstract:
1. Experimental and clinical studies have demonstrated the efficacy of inhibitors of angiotensin-converting enzyme (ACE) in a variety of cardiovascular diseases. Both structural and functional improvements have been reported. 2. Hypertension, atherosclerosis, congestive heart failure or ageing are accompanied by endothelial dysfunctions. The vasoactive endothelium-derived relaxing factors, nitric oxide, endothelium-derived hyperpolarizing factor and prostacyclin, could be involved, depending on the pathology. 3. Some of the beneficial effects of ACE inhibitors may be due to the augmented release of these endothelial factors resulting from the protection of locally produced bradykinin, particularly at the endothelial level.